Hosted on MSN
Sensory impairment, not just memory tests, is vital for our understanding of dementia, say experts
Memory problems have long been considered the primary hallmark of dementia, but a team of researchers is now challenging this view. They argue that changes in sensory perception—from vision to balance ...
The holiday season can be a stressful time for many, but for the nearly 12 million family members and friends serving as unpaid caregivers of people living with Alzheimer’s and dementia, the holidays ...
Owners often report aimless pacing, barking at nothing, soiling in the house and anxiety for no apparent reason.
While for many of us we enjoy being with family and friends during the holidays, there are many people who experience social isolation and loneliness. Social isolation and loneliness are ...
Social frailty—the fraying of close relationships and community ties—is a strong predictor of dementia risk. Could AI companions help revitalize social interactions?
Alzheimer’s disease is the most commonly diagnosed form of dementia, but it’s far from the only one. In fact, most people who ...
When I began forgetting words in midlife, I wondered if it was menopause—and worried that it was something more.
Parent, grandparent has dementia? Specialists reveal 6 daily routines to dramatically reduce anxiety
Dementia disrupts daily life but routine offers vital grounding and comfort. Experts emphasize that predictable schedules, familiar personal care and identifying agitation triggers are crucial.
New Survey Reveals Critical Gaps in Awareness and Understanding of Agitation in Alzheimer's Dementia
WASHINGTON, Nov. 12, 2025 /PRNewswire/ -- Nearly half (49%) of those caring for someone experiencing agitation symptoms as part of their Alzheimer's dementia reveal that the agitation symptoms are ...
As Lundbeck and Otsuka count on prescriptions in agitation associated with dementia due to Alzheimer’s disease (AADAD) to continue driving growth for Rexulti, the duo is supporting new research ...
NEW HAVEN, Conn., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results